L — Loews Corporation

Market sentiment is mixed-to-neutral: institutional accumulation and a late-May director buy are supportive, but the stock has pulled back from the upper part of its 52-week range and technical momentum is soft. Analyst coverage is constructive (2 buy, 2 hold, consensus 'Buy'), yet the tape has been range-bound around $111-$112, and with RSI at 34.8 there is no conviction bid right now.

Revenue has grown steadily from $3.90B in Q3 2023 to $4.73B in Q2 2026, with YoY growth between roughly 2.6% and 6.7% over the last eight quarters. Reported operating income is lumpy—Q4 2024 was an outlier at $188M—but has otherwise held in a $0.5B-$1.3B range. The real blemish is cash flow: Q1 2026 operating cash flow was only $72M and FCF was -$132M, dragging TTM FCF to roughly $2.0B versus around $3.0B a year earlier. Because revenue and reported earnings did not collapse in that quarter, this looks more like working-capital/timing than a structural decline, but it is the main reason the backward-looking growth score is muted.

At $109.82, Loews trades at 13.46x trailing earnings, slightly above its 5-year average P/E of 12.88x, while P/S of 1.22x is above the 5-year average of 1.08x. P/B is 1.18x against an ROE of roughly 8.9%. On a P/E basis the stock is fairly valued, not obviously cheap; the low PEG of 0.46 only looks compelling if you assume much higher forward EPS growth than the recent data supports.

Earnings have been stable-to-improving, but the market is paying only an average P/E because cash-flow timing, moderating P&C pricing, and heavy Boardwalk capex are capping multiple expansion. The stock is not pricing in an earnings collapse; it has simply de-rated from the high end of its 52-week range while EPS held up. If CNA underwriting stays steady and Boardwalk's $3.4B growth plan starts generating incremental cash, the stock is undervaluing normalized earnings; if Q1-style cash-flow dips or catastrophe losses repeat, the multiple will stay stuck.

As of 2026-08-27, RSI-14 was 34.8, near oversold but not at capitulation levels. Price was 2.9% below the 20-day SMA, 3.5% below the 50-day SMA, and 1.1% above the 200-day SMA. That points to a pullback within a longer-term uptrend—an early support-test zone rather than a confirmed reversal. A hold above the 200-day would be constructive, while a break below it would open up the lower end of the 52-week range.

• Commercial P&C pricing growth has moderated to roughly +2.5% YoY, reducing the rate tailwind for CNA.
• Natural gas/LNG demand and power-generation growth are tailwinds for Boardwalk Pipelines' $3.4B expansion program.
• Elevated interest rates support investment income on Loews' large portfolio, while the new 4.9% senior notes refinancing manages debt costs.
• Hurricane season in Q3-Q4 is a recurring swing factor for CNA's catastrophe losses and reserve development.
• Equity and credit market marks affect reported book value and investment income.

• Q3 2026 earnings in late October/early November 2026, especially CNA underwriting margins and catastrophe losses.
• Continued share buybacks—Loews repurchased 1.7M shares for $177M in H1 2026—support per-share book value.
• Boardwalk growth milestones, including Spire Marketing integration and pipeline/storage project executions, could drive midstream earnings higher.

• Catastrophe losses or adverse reserve development at CNA.
• Execution or cost overruns on Boardwalk's multi-year $3.4B infrastructure plan, which could pressure free cash flow.
• Interest-rate or investment-market movements hitting reported book value and earnings.
• The dividend yield is only about 0.23%, so total return depends heavily on buybacks and stock-price appreciation.

Loews is a conservatively managed, well-capitalized holding company with steady insurance cash flows and a genuine natural-gas midstream growth opportunity, but it is not a screaming bargain at 13.46x earnings. The pullback to $109.82 with RSI near 34.8 and price still above the 200-day makes it a reasonable accumulation zone for patient investors, not a high-conviction buy. Returns should come from slow EPS growth plus buybacks, with valuation roughly fair today.

I applied a 12.3x P/E to EPS_ttm of $9.35, a modest discount to the 5-year average of 12.88x to reflect moderating P&C pricing and uneven free cash flow. That yields roughly $115, slightly above the 2026-08-27 price of $109.82.